Five Proteins Biomarkers for Early Breast Cancer Detection - Research

Researchers used a Mendelian randomization approach to identify five proteins that could be used as biomarkers for early breast cancer detection.

Breast cancer is the most common type of cancer in women worldwide. Early detection is important for improving the chances of successful treatment. However, current methods for early detection, such as mammograms, are not always effective.

A new study published in the journal Nature Communications used a Mendelian randomization approach to identify five proteins that could be used as biomarkers for early breast cancer detection. The study analyzed the levels of over 3,000 proteins in plasma samples from women with and without breast cancer.

Mendelian randomization offers an alternative approach to identify causal relationships between risk factors and diseases. It utilizes genetic variants as instrumental variables to assess the impact of modifiable factors on disease risk. Circulating proteins in plasma, measurable using high-throughput methods, reflect biological processes associated with cancer and serve as potential biomarkers for cancer pathogenesis.

The researchers found that five proteins were significantly higher or lower in women with breast cancer than in women without breast cancer. These proteins were CD160, layilin (LAYN), 2’-deoxynucleoside 5’-phosphate N-hydrolase 1 (DNPH1), toll-like receptor 1 (TLR1), and leucine-rich repeat containing 37 member A2 (LRRC37A2).

The researchers believe that these proteins could be used to develop new blood tests for early breast cancer detection. They also believe that these proteins could be used to develop new treatments for breast cancer.

Five Proteins Biomarkers for Early Breast Cancer Detection - Research

Here is a table summarizing the five proteins that were identified in the study:

ProteinDescriptionAssociation with breast cancer risk
CD160A receptor expressed in most immune cellsLower levels of CD160 were found to correlate with an increase in breast cancer risk.
LAYNAn integral membrane and a talin-binding transmembrane protein that has an essential role in cell motility and adhesionHigher levels of LAYN were found to correlate with an increase in breast cancer risk.
DNPH1An enzyme involved in nucleotide metabolismHigher levels of DNPH1 were found to correlate with an increase in breast cancer risk.
TLR1A receptor that plays a role in the immune system’s response to bacterial infectionsHigher levels of TLR1 were found to correlate with an increase in breast cancer risk.
LRRC37A2A protein that has been shown to interact with the estrogen receptorLower levels of LRRC37A2 were found to correlate with an increase in breast cancer risk.

Continue to check our website soundhealthandlastingwealth.com for more articles of this kind. And, please use our comment section as well, we would love to hear from you.

Soundhealthandlastingwealth.com offer the most up-to-date information from top experts, new research, and health agencies, but our content is not meant to be a substitute for professional guidance. When it comes to the medication you're taking or any other health questions you have, always consult your healthcare provider directly.
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

New cellular atlas maps out healthy and cancerous breast tissue

  Credit: Pixabay/CC0 Public Domain WEHI researchers have documented the diversity of…

Is Sudocrem good for acne? The best way to get rid of spots

Is Sudocrem good for acne?  Acne is a painful and often embarrassing…

Progeria Patients Connect: Bridging the Gap for a Rare Disease Community

Progeria Patients Connect: Bridging the Gap for a Rare Disease Community –…

Diabetic Patients At Higher Risk of Developing Severe Influenza Symptoms, Doctor Warns

Diabetic Patients are more prone to having serious influenza symptoms. Influenza has…